Home > Products > Biosimilars

BioSIM anti-Human CD40 Antibody (Sotigalimab Biosimilar), Research Grade

Catalog: SIM0012
Cost advantage to: SIM0072
Isotype: IgG1-Kappa
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic biosimilar has the same variable regions as Sotigalimab, ideal for research. Sotigalimab is a humanized IgG1 mAb targeting CD40 (TNFRSF5/P50/CDW40), expressed on immune and non-immune cells. CD40-CD40L interaction is key for immunity; in cancer, its effects depend on engagement level. The biosimilar helps study CD40 signaling, immune activation, and anti-cancer immunotherapeutics development.
 

Specifications

Product Name BioSIM anti-Human CD40 Antibody (Sotigalimab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG1-Kappa
Target CD40
Other Names APX005M, APX-005, APX-005-M, APX-005M, CAS: 2305607-45-6
CAS 2305607-45-6
Reactivity Human
Host Species Humanized
Background This non-therapeutic biosimilar has the same variable regions as Sotigalimab, ideal for research. Sotigalimab is a humanized IgG1 mAb targeting CD40 (TNFRSF5/P50/CDW40), expressed on immune and non-immune cells. CD40-CD40L interaction is key for immunity; in cancer, its effects depend on engagement level. The biosimilar helps study CD40 signaling, immune activation, and anti-cancer immunotherapeutics development.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products